Advanced NSCLC
153P - Chemotherapy with immune-checkpoint inhibitors in first-line treatment metastatic NSCLC patients: Systematic review and literature-based meta-analysis
Authors
- A. Addeo (Geneva, Switzerland)
- G. Banna (Catania, Italy)
- G. Metro (Perugia, (PG), Italy)
- M. Di Maio (Torino, Italy)
Speakers
- A. Addeo (Geneva, Switzerland)
Prevention, Early detection, Epidemiology, Tobacco control
53P - Pulmonary tuberculosis: A hurdle to overcome for early lung cancer diagnosis in TB burden countries
Authors
- M. Akter (Dhaka, Bangladesh)
- S. Ahmed (Dhaka, Bangladesh)
Speakers
- M. Akter (Dhaka, Bangladesh)
Advanced NSCLC
141P - Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)
Authors
- L. Angelats (Badalona, Spain)
- M. Garcia Campelo (Coruna, Spain)
- R. Bernabe Caro (Sevilla, Spain)
- E. Arriola Aperribay (Barcelona, Spain)
- V. Calvo de Juan (Majadahonda, Madrid, Spain)
- A. Barba Joaquín (Barcelona, Spain)
- N. Vinolas Segarra (Barcelona, Spain)
- M. Gil Moreno (Barcelona, Barcelona, Spain)
- L. Vilà Martinez (Sabadell, Barcelona, Spain)
- O. Juan Vidal (Valencia, Spain)
- N. Vilariño Quintela (Barcelona, Spain)
- M. Cobo (Malaga, Spain)
- E. Sais (Girona, Spain)
- M. Domine Gomez (Madrid, Spain)
- N. Fernandez Nuñez (Lugo, Spain)
- J. Coves Sarto (Palma de Mallorca, Islas Baleares, Spain)
- R. Marse Fabregat (Palma de Mallorca, Spain)
- A. Esteve Gomez (Badalona, Spain)
- D. Rodríguez-Abreu (Las Palmas, Spain)
- E. Carcereny Costa (Badalona, Barcelona, Spain)
Speakers
- L. Angelats (Badalona, Spain)
Mesothelioma
197P - Effect of surgical treatment on the survival in patients with malignant pleural mesothelioma
Authors
- R. Baez-Saldana (Ciudad de México, Mexico)
- M. Marmolejo-Torres (Mexico City, Mexico)
- M. Iñiguez-García (Mexico City, Mexico)
- J. Berrios Mejía (Mexico City, Mexico)
- U. Rumbo-Nava (Mexico City, Mexico)
- O. Arrieta-Rodríguez (Mexico City, Mexico)
Speakers
- R. Baez-Saldana (Ciudad de México, Mexico)
Imaging and staging
/thumbnails/0.png)
59P - Comparison of internal target volume delineation using CT datasets of four-dimensional computed tomography in lung cancer radiotherapy
Authors
- S. BUSHRA (Mumbai, India)
- A. Tibdewal (Mumbai, India)
- N. Mummudi (Mumbai, India)
- R. Kinhikar (Mumbai, India)
- Y. Ghadi (Mumbai, India)
- J. Agarwal (Mumbai, India)
Speakers
- S. BUSHRA (Mumbai, India)
Early stage NSCLC
78P - Lung resection for cancer in patients with heart disease: Management and postoperative outcome
Authors
- F. Caushi (Tirana, Albania)
- I. Skenduli (Tirana, Albania)
- A. Hatibi (Tirana, Albania)
- A. Mezini (Tirana, Albania)
- S. Telo (Tirana, Albania)
- S. Bala (Tirana, Albania)
- E. Shima (Tirana, Albania)
- A. Cani (Tirana, Albania)
Speakers
- F. Caushi (Tirana, Albania)
Mesothelioma
199P - Safety meta-analysis of clinical trials delivering TTFields to the upper torso
Authors
- G. Ceresoli (Bergamo, Italy)
- M. Pless (Winterthur, Switzerland)
Speakers
- G. Ceresoli (Bergamo, Italy)
Early stage NSCLC
79P - Tissue microarray analysis on prognostic value of coexpression of RUNX3 and trimethylated histone H3 lysine 27 in surgically resected patients with stage I non-small cell lung cancer
Authors
- X. Chen (Fuzhou, China)
- Y. Deng (Fuzhou, China)
- Y. Shi (Fuzhou, China)
Speakers
- X. Chen (Fuzhou, China)
Advanced NSCLC
180TiP - An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer
Authors
- J. Spicer (London, United Kingdom)
- M. Provencio (Madrid, Spain)
- P. Garrido Lopez (Madrid, Spain)
- J. Bosch-Barrera (Girona, Spain)
- F. De Castro Carpeño (Madrid, Spain)
- E. Felip (Barcelona, Spain)
- J. Trigo (Malaga, Spain)
- S. Viteri (Barcelona, Spain)
- E. Coart (Ottignies, Belgium)
- E. Schmidt (Kenilworth, NJ, United States of America)
- A. Christiansen (Copenhagen, Denmark)
- M. Zocca (Copenhagen, Denmark)
- M. Andersen (Copenhagen, Denmark)
- E. Ehrnrooth (Copenhagen, Denmark)
- L. Paz-Ares (Madrid, Spain)
Speakers
- J. Spicer (London, United Kingdom)
Tumour biology and pathology
15P - TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor
Authors
- J. Cordoba Ortega (Lleida, Spain)
- A. Salud (Lerida, Spain)
- S. Morales (Lerida, Spain)
- J. Veas (Lerida, Spain)
- A. Rodriguez (Lerida, Spain)
Speakers
- J. Cordoba Ortega (Lleida, Spain)
Early stage NSCLC
80P - High blood platelets levels (BPL): A prognostic factor in patients with early or locally advanced non-small cell lung cancer (NSCLC)
Authors
- J. Cordoba Ortega (Lleida, Spain)
- A. Salud (Lerida, Spain)
- S. Morales (Lerida, Spain)
- J. Veas (Lerida, Spain)
- A. Rodriguez (Lerida, Spain)
Speakers
- J. Cordoba Ortega (Lleida, Spain)
Advanced NSCLC
169P_PR - Benefit of immunotherapy (IT) in advanced non-small cell lung cancer (NSCLC) in elderly patients (EP)
Authors
- E. Corral de la Fuente (Madrid, Spain)
- A. Barquín García (Madrid, Spain)
- C. Saavedra Serrano (Madrid, Spain)
- M. Olmedo García (Madrid, Spain)
- R. Martin Huertas (Madrid, Spain)
- J. Serrano Domingo (Madrid, Spain)
- V. Albarrán Artahona (Madrid, Spain)
- A. Gómez Rueda (Madrid, Spain)
Speakers
- E. Corral de la Fuente (Madrid, Spain)